Clinical Trial Update: The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed [Phase 4]

View source ↗

Summary

Phase 4 trial comparing terlipressin to octreotide for control of variceal bleeding in patients with portal hypertension due to cirrhosis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Esophageal Variceal Hemorrhage
• Portal Hypertension

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)
• Terlipressin (terlipressin)

Snippet

Sponsor: Aga Khan University | Conditions: Portal Hypertension, Cirrhosis | Phase 4 | Status: COMPLETED